U.K. COVID-19 Immunity Passports Enter Trial Phases

Subscribe To Read This Insight

By Sam Gazeley | 1Q 2021 | IN-6058


The Mvine-IProov Passport Enters Final Testing


It was announced in January 2021 that the United Kingdom had pushed a COVID-19 immunity and vaccination passport into live testing. The passport, developed by deep-tech solutions provider Mvine and facial biometric authentication company iProov with backing from Innovate UK, will display the citizen’s registered vaccination status without the need for their identity to be disclosed. The prototype credential will now go into testing within the National Health Service (NHS) with the aim of completing two successful trials by the end of March 2021. This will be required to establish trust in the digital credential, which is needed to enable its deployment at scale in local areas.

The Mvine-iProov passport has been stated to integrate with existing NHS infrastructure and databases, enabling it to comply with pre-existing national requirements, a typical stumbling block for the introduction of new credentials. The proof of vaccination status, which can be verified in an online and offline environment, is accomplished by utilizing a mathematical model of the citizen&rs…

You must be a subscriber to view this ABI Insight.
To find out more about subscribing contact a representative about purchasing options.